Burra Patrizia, Belli Luca Saverio, Ginanni Corradini Stefano, Volpes Riccardo, Marzioni Marco, Giannini Edoardo, Toniutto Pierluigi
Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Italy.
Department of Hepatology, Niguarda Hospital, Milan, Italy.
Dig Liver Dis. 2017 Mar;49(3):241-253. doi: 10.1016/j.dld.2016.12.027. Epub 2016 Dec 31.
The present document contains the recommendations of an expert panel of transplant hepatologists, appointed by the Italian Association for the Study of the Liver (AISF), on how to manage the most common aspects of liver transplantation: the topics covered include: new treatments for HCV in patients on the waiting list for liver transplantation; antiviral treatments in patients with HCV recurrence after liver transplantation; prophylaxis for HBV recurrence after liver transplantation; indications for liver transplantation in alcoholic liver disease; and Immunosuppressive therapy. The statements on each topic were approved by participants at the AISF Transplant Hepatologist Expert Meeting (organized by the Permanent Committee on Liver Transplantation in Mondello on 4-5 October 2015), and are graded according to the Oxford classification of levels of evidence.
本文件包含由意大利肝脏研究协会（AISF）任命的移植肝病专家小组关于肝移植最常见方面管理的建议：涵盖的主题包括：肝移植等待名单上丙型肝炎患者的新治疗方法；肝移植后丙型肝炎复发患者的抗病毒治疗；肝移植后乙肝复发的预防；酒精性肝病的肝移植指征；以及免疫抑制治疗。每个主题的声明均经AISF移植肝病专家会议（由蒙代洛肝脏移植常设委员会于2015年10月4日至5日组织）的参与者批准，并根据牛津证据水平分类进行分级。
